Table 1.
Correlation between GOLT1B expression and clinicopathological features in CRC patients
| Variables | Low GOLT1B (n = 72) | High GOLT1B (n = 152) | P value |
|---|---|---|---|
| Gender | 1.0000 | ||
| Male | 41 (56.9%) | 87 (57.2%) | |
| Female | 31 (43.1%) | 65 (42.8%) | |
| Median age | 0.0099** | ||
| < 67 years | 45 (62.5%) | 66 (42.4%) | |
| ≥ 67 years | 27 (37.5%) | 86 (56.6%) | |
| pT stage | 0.6430 | ||
| T1 | 4 (5.6%) | 13 (8.5%) | |
| T2 | 19 (26.4%) | 31 (20.4%) | |
| T3 | 41 (56.9%) | 91 (59.9%) | |
| T4 | 8 (11.1%) | 17 (11.2%) | |
| pN stage | < 0.0002*** | ||
| N0 | 63 (87.5%) | 98 (64.5%) | |
| N1 | 7 (9.7%) | 44 (28.9%) | |
| N2 | 2 (2.8%) | 10 (6.6%) | |
| pM stage | 0.0005*** | ||
| M0 | 71 (98.6%) | 127 (83.6%) | |
| M1 | 1 (1.4%) | 25 (16.4%) | |
| Histological grade | 0.3711 | ||
| G1 | 3 (4.2%) | 8 (5.3%) | |
| G2 | 40 (55.6%) | 93 (61.2%) | |
| G3 | 29 (40.2%) | 51 (33.5%) |
All data are shown as numbers and percentages. Low GOLT1B is defined as IHC score < 5 and High GOLT1B is defined as IHC score ≥ 5. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001